What amount sold does NeuraMedica Inc. report in Form D filings?

The latest linked filings report $1.8M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was NeuraMedica Inc.'s most recent SEC filing?

NeuraMedica Inc.'s most recent Form D filing was on 2024-11-26.

How many investors does NeuraMedica Inc. have?

The most recent Form D filing lists 13 investor(s).

NeuraMedica Inc.

CIK: 0001744491·Biotechnology·OREGON CITY, OR·Corporation

Reported Sold

$1,849,622

Total Filings

Identified Offerings

Last Filed

Nov 26, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Nov 26, 2024Form D/A — Amendment

Reported sold: $709,622 · Target: $1,000,000

Rule 506(b)·13 investors

Changed: Reported amount sold, Reported investors

Dec 11, 2023Form D/A — Amendment

Reported sold: $50,000 · Target: $1,000,000

Rule 506(b)·1 investor

Changed: Offering target

Jul 10, 2023Form D — New notice

Reported sold: $50,000 · Target: $500,000

Rule 506(b)·1 investor

Feb 4, 2021Form D — New notice

Reported sold: $1,100,000 · Target: $1,100,000

Rule 506(b)·5 investors

Jun 22, 2018Form D — New notice

Reported sold: $40,000 · Target: $150,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

40%

Latest reported sold across 3 identified offerings

$1,849,622

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Rachel Dreilinger

Related Person

Appears on 5 filings

Neil Roundy

Related Person

Appears on 5 filings

Michael Tippie

Related Person

Appears on 4 filings

Coni Rosati

Related Person

Appears on 1 filing

John Alleman

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 26, 2024	Amendment	$1,000,000	$709,622	13
Dec 11, 2023	Amendment	$1,000,000	$50,000	1
Jul 10, 2023	New	$500,000	$50,000	1
Feb 4, 2021	New	$1,100,000	$1,100,000	5
Jun 22, 2018	New	$150,000	$40,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

511 Therapeutics, Inc.

Biotechnology

Offering target: $1,000,000

Filed Oct 30, 2026